Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. QIAGEN N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

06/11/2021 | 04:05pm EDT

DGAP Voting Rights Announcement: QIAGEN N.V.
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11.06.2021 / 22:04
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The AFM (the Netherlands Authority For the Financial Markets) has informed us on June 9, 2021 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 07 jun 2021
Person obliged to notify: BlackRock, Inc.
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Ordinary share 31.808.110,00 34.968.872,00 Real Real Indirectly - BlackRock, Inc.  
Contract for difference 303.945,00 303.945,00 Potential Potential Indirectly - BlackRock, Inc. In Cash
Ordinary share 1.058.643,00 1.058.643,00 Potential Potential Indirectly - BlackRock, Inc. Physical Delivery
 


Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 14,37 % 0,00 % 0,00 % 13,78 % 0,59 %
Voting rights 15,74 % 0,00 % 0,00 % 15,15 % 0,59 %
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=113490



11.06.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

1206067  11.06.2021 

fncls.ssp?fn=show_t_gif&application_id=1206067&application_name=news&site_id=zonebourse_sftp

© EQS 2021
All news about QIAGEN N.V.
07/23QIAGEN N : UBS Adjusts Qiagen's Price Target to $55 From $58; Neutral Rating Kep..
MT
07/23QIAGEN NV : UBS reaffirms its Neutral rating
MD
07/20QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
07/20QIAGEN N : Disclosure according to Article 5 Section (1) and (6) of the EU Regul..
PU
07/20DGAP-CMS : QIAGEN N.V.: Release of a capital market information
DJ
07/15QIAGEN NV : Gets a Buy rating from Berenberg
MD
07/14QIAGEN N : Kepler Cheuvreux Downgrades Qiagen to Hold From Buy; Price Target is ..
MT
07/14QIAGEN N : Citigroup Adjusts Qiagen's Price Target to $58 From $65, Reiterates B..
MT
07/14ANALYST RECOMMENDATIONS : Alibaba, Gap, Pepsico, Ralph Lauren, Tencent Music Ent..
07/14QIAGEN NV : Jefferies reiterates its Neutral rating
MD
More news
Financials (USD)
Sales 2021 2 144 M - -
Net income 2021 451 M - -
Net Debt 2021 928 M - -
P/E ratio 2021 26,4x
Yield 2021 -
Capitalization 11 875 M 11 875 M -
EV / Sales 2021 5,97x
EV / Sales 2022 6,09x
Nbr of Employees 5 750
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
QIAGEN N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 51,99 $
Average target price 52,96 $
Spread / Average Target 1,87%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Chief Financial Officer & Managing Director
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-1.63%11 089
MODERNA, INC.233.90%88 312
LONZA GROUP AG24.05%53 538
IQVIA HOLDINGS INC.39.02%47 022
CELLTRION, INC.-25.21%32 170
SEAGEN INC.-16.87%28 525